Academic Journal

A phase 1 open-label pilot study of low-dose interleukine-2 immunotherapy in patients with Alzheimer’s disease

التفاصيل البيبلوغرافية
العنوان: A phase 1 open-label pilot study of low-dose interleukine-2 immunotherapy in patients with Alzheimer’s disease
المؤلفون: Faridar, Alireza, Eid, Abdulmunaim M., Thome, Aaron D., Zhao, Weihua, Beers, David R., Pascual, Maria B., Nakawah, Mohammad O., Roman, Gustavo C., Davis, Charles S., Grundman, Michael, Masdeu, Joseph C., Appel, Stanley H.
المساهمون: Alzheimer's Association
المصدر: Translational Neurodegeneration ; volume 12, issue 1 ; ISSN 2047-9158
بيانات النشر: Springer Science and Business Media LLC
سنة النشر: 2023
الوصف: Trial registration ClinicalTrials.gov Identifier: NCT05821153, Registered April 20 2023, Retrospectively registered, https://classic.clinicaltrials.gov/ct2/show/NCT05821153
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1186/s40035-023-00387-5
DOI: 10.1186/s40035-023-00387-5.pdf
DOI: 10.1186/s40035-023-00387-5/fulltext.html
الاتاحة: http://dx.doi.org/10.1186/s40035-023-00387-5
https://link.springer.com/content/pdf/10.1186/s40035-023-00387-5.pdf
https://link.springer.com/article/10.1186/s40035-023-00387-5/fulltext.html
Rights: https://creativecommons.org/licenses/by/4.0 ; https://creativecommons.org/licenses/by/4.0
رقم الانضمام: edsbas.E96A5902
قاعدة البيانات: BASE
الوصف
DOI:10.1186/s40035-023-00387-5